PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
40.34%
Revenue growth above 1.5x AVGO's 6.52%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
43.22%
Gross profit growth above 1.5x AVGO's 8.76%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
101.58%
EBIT growth above 1.5x AVGO's 36.71%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
101.58%
Operating income growth above 1.5x AVGO's 36.71%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
114.23%
Net income growth above 1.5x AVGO's 9.32%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
108.33%
EPS growth above 1.5x AVGO's 9.09%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
110.00%
Diluted EPS growth of 110.00% while AVGO is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.75%
Share count expansion well above AVGO's 0.99%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.49%
Diluted share count expanding well above AVGO's 0.68%. Michael Burry would fear significant dilution to existing owners' stakes.
-2.34%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
148.91%
OCF growth above 1.5x AVGO's 4.61%. David Dodd would confirm a clear edge in underlying cash generation.
176.32%
FCF growth above 1.5x AVGO's 5.58%. David Dodd would verify if the firm’s strategic investments yield superior returns.
140.01%
10Y revenue/share CAGR under 50% of AVGO's 434.54%. Michael Burry would suspect a lasting competitive disadvantage.
112.09%
5Y revenue/share CAGR under 50% of AVGO's 343.33%. Michael Burry would suspect a significant competitive gap or product weakness.
105.29%
3Y revenue/share CAGR similar to AVGO's 116.03%. Walter Schloss would assume both companies experience comparable short-term cycles.
55.57%
10Y OCF/share CAGR under 50% of AVGO's 1351.20%. Michael Burry would worry about a persistent underperformance in cash creation.
111.44%
Below 50% of AVGO's 678.79%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
204.65%
3Y OCF/share CAGR similar to AVGO's 223.95%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
400.09%
Net income/share CAGR at 75-90% of AVGO's 474.79%. Bill Ackman would press for strategic moves to boost long-term earnings.
243.06%
5Y net income/share CAGR above 1.5x AVGO's 99.69%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
392.86%
3Y net income/share CAGR 1.25-1.5x AVGO's 280.16%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
183.48%
Equity/share CAGR of 183.48% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
51.19%
Below 50% of AVGO's 420.76%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
33.04%
Below 50% of AVGO's 292.62%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.76%
Below 50% of AVGO's 210.49%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
29.35%
AR growth well above AVGO's 16.59%. Michael Burry fears inflated revenue or higher default risk in the near future.
30.33%
Inventory growth well above AVGO's 9.15%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
28.83%
Asset growth above 1.5x AVGO's 0.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
17.96%
BV/share growth above 1.5x AVGO's 0.62%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
101.92%
Debt growth far above AVGO's 0.04%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
6.57%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
8.92%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.